MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202617077019 A) filed by Rubedo Life Sciences, Inc. on June 22, 2026, for Carbon Linked Bcl Inhibitors And Senolytic Compounds And Uses Thereof.
Inventors include Hadd, Michael; and Jennings, Andrew John.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: The present invention relates to compounds that kill senescent cells i.e., senolytic compounds and compounds which inhibit BCL-2 protein family (BCL-2, BCL-XL, BCL-W, MCL-1, A1, BCL-B). The present invention also provides compounds and methods for treating senescence-associated diseases or disorders, and compounds and methods for treating disease...